EligibleTrials

Clinical trials recruiting for BRAF Gene Mutation

3
Recruiting trials
19
US states with sites
6
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 2Phase 2 1Not applicable 1

Drugs and treatments being studied

InterventionTrials
Binimetinib1
Cetuximab1
Dabrafenib1
Encorafenib1
FOLFIRI1
FOLFOX6/FOLFOX71
Gemcitabine1
Nab-paclitaxel1
Nilotinib 100mg1
Nilotinib 200mg1
Nilotinib 300mg1
Nilotinib 400mg1

Where trials are recruiting (top US states)

StateRecruiting trials
Tennessee2
Arizona1
California1
Colorado1
Connecticut1
District of Columbia1
Iowa1
Kentucky1
Massachusetts1
Michigan1
Minnesota1
Missouri1

Top cities

Nashville, Tennessee 2Aurora, Colorado 1Boston, Massachusetts 1Cleveland, Ohio 1Durham, North Carolina 1Easton, Pennsylvania 1Fairfax, Virginia 1Gilbert, Arizona 1Grand Rapids, Michigan 1Houston, Texas 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for BRAF Gene Mutation often also study these conditions. Each links to its own recruiting-trial list.

Colorectal cancer 1359Thyroid Carcinoma 3Thyroid Cancer 21Solid Carcinoma 6Recurrent Lung Non-Small Cell Carcinoma 12Ras (KRAS or NRAS) Gene Mutation 3Non-small cell lung cancer 507Metastatic Melanoma 40Metastatic Lung Non-Small Cell Carcinoma 20Metastatic Lung Cancer 12

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for BRAF Gene Mutation trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.